Xiaowei Zeng

12.7k total citations · 7 hit papers
132 papers, 11.1k citations indexed

About

Xiaowei Zeng is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Xiaowei Zeng has authored 132 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Biomedical Engineering, 59 papers in Biomaterials and 45 papers in Molecular Biology. Recurrent topics in Xiaowei Zeng's work include Nanoplatforms for cancer theranostics (66 papers), Nanoparticle-Based Drug Delivery (53 papers) and RNA Interference and Gene Delivery (18 papers). Xiaowei Zeng is often cited by papers focused on Nanoplatforms for cancer theranostics (66 papers), Nanoparticle-Based Drug Delivery (53 papers) and RNA Interference and Gene Delivery (18 papers). Xiaowei Zeng collaborates with scholars based in China, Singapore and United States. Xiaowei Zeng's co-authors include Lin Mei, Wei Tao, Hongzhong Chen, Zimu Li, Gan Liu, Laiqiang Huang, Xiaoyuan Ji, Wenfeng Zeng, Yanli Zhao and Xusheng Wang and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Xiaowei Zeng

132 papers receiving 11.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced Nanomedicine

2019 880 citations Xiaowei Zeng, Hongzhong Chen et al. ACS Nano profile →
Black Phosphorus Nanosheets as a Robust Delivery Platform for Cancer Theranostics

2016 799 citations Wei Tao, Xiaowei Zeng et al. profile →
Polydopamine‐Modified Black Phosphorous Nanocapsule with Enhanced Stability and Photothermal Performance for Tumor Multimodal Treatments

2018 533 citations Xiaowei Zeng, Miaomiao Luo et al. profile →
pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy

2017 403 citations Wei Cheng, Junpeng Nie et al. ACS Applied Materials & Interfaces profile →
Two‐Dimensional Antimonene‐Based Photonic Nanomedicine for Cancer Theranostics

2018 360 citations Wei Tao, Xiaowei Zeng et al. profile →
Biofilm microenvironment triggered self-enhancing photodynamic immunomodulatory microneedle for diabetic wound therapy

2023 190 citations Chendi Ding, Zimu Li et al. Nature Communications profile →
Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy

2025 38 citations Shunyu Yao, Jingjing Luo et al. Nature Communications profile →

Peers

Countries citing papers authored by Xiaowei Zeng

Since Specialization

Citations

This map shows the geographic impact of Xiaowei Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Zeng more than expected).

Fields of papers citing papers by Xiaowei Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Zeng. The network helps show where Xiaowei Zeng may publish in the future.

Co-authorship network of co-authors of Xiaowei Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Zeng. A scholar is included among the top collaborators of Xiaowei Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Zeng. Xiaowei Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy breakdown → 2025 ·Nature Communications ·(unknown), Shunyu Yao, Jingjing Luo, Chendi Ding, Qili Huang, Yao Yang, Zhaoqing Shi, (unknown), Yu‐Chen Pan, Xiaowei Zeng, Dong‐Sheng Guo, Hongzhong Chen	38
2	Glucose Metabolism-Modifying Natural Materials for Potential Feed Additive Development 2024 ·Pharmaceutics ·Wei Lin, (unknown), (unknown), (unknown), Xiaowei Zeng	2
3	An “AND” logic gate–based supramolecular therapeutic nanoplatform for combatting drug-resistant non–small cell lung cancer 2024 ·Science Advances ·(unknown), Chendi Ding, (unknown), (unknown), Yinglong Wu, (unknown), Zimu Li, Zhaoqing Shi, Lin Mei, Xiaowei Zeng, Yanli Zhao, Hongzhong Chen	12
4	Self-driven nanoprodrug platform with enhanced ferroptosis for synergistic photothermal-IDO immunotherapy 2023 ·Biomaterials ·Ping Huang, Yao Yang, Wenyan Wang, Zimu Li, Nansha Gao, Hongzhong Chen, Xiaowei Zeng	71
5	Polydopamine surface-modified hyperbranched polymeric nanoparticles for synergistic chemo/photothermal therapy of oral cancer 2023 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Zimu Li, Yi Zhang, Xiaowei Zeng, (unknown), (unknown)	10
6	Dextran-based micelles for combinational chemo-photodynamic therapy of tumors via in vivo chemiluminescence 2023 ·Carbohydrate Polymers ·Chendi Ding, Zhaoqing Shi, Meitong Ou, (unknown), Li Huang, Wenyan Wang, Qili Huang, (unknown), Chunbo Chen, Xiaowei Zeng, Hongzhong Chen, Lin Mei	22
7	NIR-dye bridged human serum albumin reassemblies for effective photothermal therapy of tumor 2023 ·Nature Communications ·Zhaoqing Shi, Miaomiao Luo, Qili Huang, Chendi Ding, Wenyan Wang, Yinglong Wu, Jingjing Luo, Chuchu Lin, Ting Chen, Xiaowei Zeng, Lin Mei, Yanli Zhao, Hongzhong Chen	54
8	Rapidly separating dissolving microneedles with sustained-release colchicine and stabilized uricase for simplified long-term gout management 2023 ·Acta Pharmaceutica Sinica B ·Yao Yang, Zimu Li, Ping Huang, (unknown), Jinyuan Li, (unknown), Jiahui Lin, Jingwen Hu, Zhuoxian Zhao, Yongkang Yu, Hongzhong Chen, Xiaowei Zeng, Lin Mei	41
9	Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy 2022 ·ACS Nano ·Chendi Ding, Chunbo Chen, Xiaowei Zeng, Hongzhong Chen, Yanli Zhao	120
10	Mussel-Derived, Cancer-Targeting Peptide as pH-Sensitive Prodrug Nanocarrier 2019 ·ACS Applied Materials & Interfaces ·Yue Ma, Peiyan He, Xiaohua Tian, Guang-Lei Liu, Xiaowei Zeng, Guoqing Pan	56
11	Dynamically PEGylated and Borate‐Coordination‐Polymer‐Coated Polydopamine Nanoparticles for Synergetic Tumor‐Targeted, Chemo‐Photothermal Combination Therapy 2018 ·Small ·Shucheng Liu, Jianming Pan, Jinxin Liu, Yue Ma, Fengxian Qiu, Lin Mei, Xiaowei Zeng, Guoqing Pan	186
12	DACHPt-Loaded Nanoparticles Self-assembled from Biodegradable Dendritic Copolymer Polyglutamic Acid-b-D-α-Tocopheryl Polyethylene Glycol 1000 Succinate for Multidrug Resistant Lung Cancer Therapy 2018 ·Frontiers in Pharmacology ·Hsiang‐i Tsai, Lijuan Jiang, Xiaowei Zeng, Hongbo Chen, Zihuang Li, Wei Cheng, Jinxie Zhang, Jie Pan, Dong Wan, Li Gao, Zhenhua Xie, Laiqiang Huang, Lin Mei, Liu Gan	15
13	Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects 2017 ·Drug Delivery ·Junpeng Nie, Wei Cheng, (unknown), Gan Liu, Yuhan Chen, Xusheng Wang, Chaoyu Liang, Wei Tao, Yinping Wei, Xiaowei Zeng, Lin Mei	50
14	Progress on the autophagic regulators and receptors in plants. 2016 ·PubMed ·Xiaowei Zeng, Cuicui Liu, (unknown), Hongwu Bian, Muyuan Zhu	2
15	Investigation and intervention of autophagy to guide cancer treatment with nanogels 2016 ·Nanoscale ·Xu Dong Zhang, Xin Liang, Jianjun Gu, Danfeng Chang, Jinxie Zhang, Zhaowei Chen, Yanqi Ye, Chao Wang, Wei Tao, Xiaowei Zeng, Gan Liu, Yongjun Zhang, Lin Mei, Zhen Gu	41
16	Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy 2015 ·Journal of Colloid and Interface Science ·Danfeng Chang, Yongfeng Gao, Lijun Wang, Gan Liu, Yuhan Chen, Teng Wang, Wei Tao, Lin Mei, Laiqiang Huang, Xiaowei Zeng	216
17	Enhancing Therapeutic Effects of Docetaxel-Loaded Dendritic Copolymer Nanoparticles by Co-Treatment with Autophagy Inhibitor on Breast Cancer 2014 ·Theranostics ·Xu Dong Zhang, Ying Yang, Xin Liang, Xiaowei Zeng, Zhigang Liu, Wei Tao, Xiaojun Xiao, Hongbo Chen, Laiqiang Huang, Lin Mei	61
18	Surface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy 2013 ·Nanoscale Research Letters ·Yi Zheng, Hongbo Chen, Xiaowei Zeng, Zhigang Liu, Xiaojun Xiao, (unknown), Dayong Gu, Lin Mei	47
19	Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer 2013 ·Biomaterials ·Xiaowei Zeng, Tao Wei, Lin Mei, Laiqiang Huang, Chunyan Tan, Si‐Shen Feng	245
20	Synthesis, characterization and adsorption performance of a novel post-crosslinked adsorbent 2010 ·Journal of Colloid and Interface Science ·Xiaowei Zeng, (unknown), Ning Ma, Yunge Fan, Chunhong Wang, Rongfu Shi	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact